Myron Levin

Credentials: · ·

History

Persistence of Immune Responses to the Recombinant Zoster Vaccine in Immune Compromised Hosts with End-Stage Renal Disease with and Without Kidney Transplantation
National Institute of Allergy and Infectious Diseases · U01
PI · $3.5M · University of Colorado Denver
2019–2024
U of Colorado Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Project lead · $66.3K · University of Colorado Denver
2008–2009
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $347.3K · University of Colorado Denver
1997–2007
Gene Expression in Acute and Chronic Neurologic Disease
National Institute of Neurological Disorders and Stroke · P01
Project lead · $147.8K · University of Colorado Denver
1997–1998

Shingrix In Recipients of Allogeneic Transplants
Principal investigator · Recruiting · Phase 2
University of Colorado, Denver
2023–2030
Shingrix in Renal Transplant Recipients
Principal investigator · Recruiting · Phase 3
University of Colorado, Denver
2023–2029
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
Principal investigator · Withdrawn · Phase 4
University of Colorado, Denver
2021–2022
Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50-59 and 70-85 Year Olds
Principal investigator · Completed · Phase 1
University of Colorado, Denver
2014–2020